Federal contract award
75A50120C00034
DEVELOPMENT OF MRNA VACCINE TO LICENSURE FOR THE PREVENTION OF COVID-19. CLIN 0001 - PRE-AWARD COST, CLIN 0002 - DEVELOPMENT OF MRNA VACCINE TO BLA AND CLIN 0003 - DOMESTIC MANUFACTURING SCALE-OUT
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | BARDA - ASPR / DAAPPO / BARDA DCMA |
| NAICS | 325414 — Biological Product (except Diagnostic) Manufacturing |
| PSC | AN11 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | COST PLUS FIXED FEE |
| Obligations | $1.8B |
| Current contract value | $1.8B |
| Potential contract value / ceiling | $1.8B |
| Start date | Apr 3, 2020 |
| Current end date | Jun 15, 2025 |
| Potential end date | Jun 15, 2025 |
| Latest award activity | Apr 10, 2025 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 24 of 24 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Apr 10, 2025 | P00024 | $0 | THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (HHS), OFFICE OF THE ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE (ASPR), BIOMEDICAL ADVANCED RESEARCH AND DEVELOPMENT AUTHORITY (BARDA) REQUIRES THE CONTRACTOR(S) TO DEVELOP A MRNA VACCINE TO LICENSUR |
| Feb 13, 2025 | P00023 | $0 | THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (HHS), OFFICE OF THE ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE (ASPR), BIOMEDICAL ADVANCED RESEARCH AND DEVELOPMENT AUTHORITY (BARDA) REQUIRES THE CONTRACTOR(S) TO DEVELOP A MRNA VACCINE TO LICENSUR |
| Oct 11, 2024 | P00022 | $0 | THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (HHS), OFFICE OF THE ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE (ASPR), BIOMEDICAL ADVANCED RESEARCH AND DEVELOPMENT AUTHORITY (BARDA) REQUIRES THE CONTRACTOR(S) TO DEVELOP A MRNA VACCINE TO LICENSUR |
| Jul 3, 2024 | P00021 | $0 | THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (HHS), OFFICE OF THE ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE (ASPR), BIOMEDICAL ADVANCED RESEARCH AND DEVELOPMENT AUTHORITY (BARDA) REQUIRES THE CONTRACTOR(S) TO DEVELOP A MRNA VACCINE TO LICENSUR |
| Dec 1, 2023 | P00020 | $0 | THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (HHS), OFFICE OF THE ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE (ASPR), BIOMEDICAL ADVANCED RESEARCH AND DEVELOPMENT AUTHORITY (BARDA) REQUIRES THE CONTRACTOR(S) TO DEVELOP A MRNA VACCINE TO LICENSUR |
| Sep 21, 2023 | P00019 | $47.7M | THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (HHS), OFFICE OF THE ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE (ASPR), BIOMEDICAL ADVANCED RESEARCH AND DEVELOPMENT AUTHORITY (BARDA) REQUIRES THE CONTRACTOR(S) TO DEVELOP A MRNA VACCINE TO LICENSUR |
| Jun 28, 2023 | P00018 | $0 | THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (HHS), OFFICE OF THE ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE (ASPR), BIOMEDICAL ADVANCED RESEARCH AND DEVELOPMENT AUTHORITY (BARDA) REQUIRES THE CONTRACTOR(S) TO DEVELOP A MRNA VACCINE TO LICENSUR |
| Jun 21, 2023 | P00017 | $0 | THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (HHS), OFFICE OF THE ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE (ASPR), BIOMEDICAL ADVANCED RESEARCH AND DEVELOPMENT AUTHORITY (BARDA) REQUIRES THE CONTRACTOR(S) TO DEVELOP A MRNA VACCINE TO LICENSUR |
| Mar 31, 2023 | P00016 | $0 | THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (HHS), OFFICE OF THE ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE (ASPR), BIOMEDICAL ADVANCED RESEARCH AND DEVELOPMENT AUTHORITY (BARDA) REQUIRES THE CONTRACTOR(S) TO DEVELOP A MRNA VACCINE TO LICENSUR |
| Dec 16, 2022 | P00015 | $0 | THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (HHS), OFFICE OF THE ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE (ASPR), BIOMEDICAL ADVANCED RESEARCH AND DEVELOPMENT AUTHORITY (BARDA) REQUIRES THE CONTRACTOR(S) TO DEVELOP A MRNA VACCINE TO LICENSUR |
| Sep 23, 2022 | P00014 | $0 | THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (HHS), OFFICE OF THE ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE (ASPR), BIOMEDICAL ADVANCED RESEARCH AND DEVELOPMENT AUTHORITY (BARDA) REQUIRES THE CONTRACTOR(S) TO DEVELOP A MRNA VACCINE TO LICENSUR |
| May 24, 2022 | P00013 | $0 | THE PURPOSE OF THIS NO COST MODIFICATION IS TO INCORPORATE HHSAR CLAUSE 352.232-71 - ELECTRONIC SUBMISSION OF PAYMENT REQUESTS (FEB 2022), INTO SECTION I OF THE CONTRACT AND TO UPDATE INVOICE INSTRUCTIONS IN SECTION G.4 OF THE CONTRACT. THE TOTAL |
| Feb 23, 2022 | P00012 | $308.5M | THE PURPOSE OF THIS MODIFICATION IS TO 1)PROVIDE FUNDING TO SUPPORT THE ADDITIONAL SCOPE OF THE CLINICAL DEVELOPMENT PLAN FOR THE ADOLESCENT STUDY P203 (WBS 1.4.2.3), PEDIATRIC STUDY P204 (WBS 1.4.2.4) AND PHASE 3 PIVOTAL STUDY P301 (WBS 1.4.3.1) A |
| Nov 1, 2021 | P00011 | $0 | THE PURPOSE OF THIS NO COST BILATERAL MODIFICATION IS TO: ? INCORPORATE EXECUTIVE ORDER 14042 - FAR DEVIATION CLAUSE 52.223-99, ENSURING ADEQUATE COVID SAFETY PROTOCOLS FOR FEDERAL CONTRACTORS INTO SECTION I OF THE CONTRACT. ? UPDATE SECTION G.8 ? |
| Sep 2, 2021 | P00010 | $0 | THE PURPOSE OF THIS MODIFICATION IS TO RESCIND THE DEFENSE PRIORITY AND ALLOCATIONS SYSTEM (DPAS) RATING ON CONTRACT # 75A50120C00034 EFFECTIVE THE DATE OF THE LETTER DATED JULY 13, 2021. THE DPAS PRIORITY RATING WAS ADDED IN MODIFICATION P00004. |
| Jun 10, 2021 | P00009 | $144.1M | THE PURPOSE OF THIS MODIFICATION IS TO SUPPORT THE ADDITIONAL SCOPE OF THE CLINICAL DEVELOPMENT PLAN (CLIN 0002) FOR THE P204 PEDIATRICS STUDY (0-<12) WBS 1.4.2.4 IN THE AMOUNT OF $144,140,941. THE P204 STUDY IS A PHASE 2/3 STUDY TO EVALUATE TH |
| Mar 16, 2021 | P00008 | $236.4M | THE PURPOSE OF THIS MODIFICATION IS TO SUPPORT THE ADDITIONAL SCOPE OF THE CLINICAL DEVELOPMENT PLAN (CLIN 0002) WHICH INCLUDES INCREASES THE P301 (EFFICACY) (WBS 1.4.3.1); CLINICAL (FTES AND DIGITAL CLINICAL SYSTEM) (WBS 1.4); BIOLOGICS LICENSE AP |
| Mar 11, 2021 | P00007 | $62.7M | THE PURPOSE OF THIS MODIFICATION IS TO SUPPORT THE ADDITIONAL SCOPE OF THE CLINICAL DEVELOPMENT PLAN INCLUDING DIRECT INCREASES TO THE CLINICAL SUBCONTRACTORS ON THE P201 (WORK BREAKDOWN STRUCTURE 1.4.2.1), THE PEDIATRIC STUDIES P203 (WBS 1.4.2.3) AN |
| Feb 15, 2021 | P00006 | $0 | THE PURPOSE OF THIS MODIFICATION IS TO 1)IDENTIFY THE BATCHES/LOTS THAT HAVE BEEN TRANSFERRED FROM MODERNA (CATALENT) TO CDC AND 2) ESTABLISH WHEN PPQ ACTIVITIES BECOME OUTSIDE OF THE SCOPE OF THIS CONTRACT AND WILL NOT BE FUNDED BY BARDA THIS MO |
| Sep 14, 2020 | P00005 | $0 | THE PURPOSE OF THIS MODIFICATION IS TO REVISE THE STATEMENT OF WORK (SOW) TO REFLECT RECENT FEEDBACK FROM THE FDA AND OWS ON THE CLINICAL DEVELOPMENT PLAN, AND TO REALLOCATE THE RESULTING FUNDING TO THE ONGOING MRNA-1273-P301 CLINICAL STUDY. |
| Jul 25, 2020 | P00003 | $471.6M | THE PURPOSE OF THIS MODIFICATION IS TO SUPPORT THE ADDITIONAL SCOPE OF THE CLINICAL DEVELOPMENT PLAN INCLUDING DIRECT INCREASES TO THE CLINICAL SUBCONTRACTORS ON THE P201 (WORK BREAKDOWN STRUCTURE 1.4.2.1) AND P301 (WORK BREAKDOWN STRUCTURE 1.4.3.1) |
| Jun 3, 2020 | P00002 | $0 | THE PURPOSE OF THIS MODIFICATION IS TO ADD THE REVISED STATEMENT OF WORK (SOW) DATED JUNE 3, 2020 FOR OPTION CLIN 0003. THE CLIN VALUE REMAINS AT UNCHANGED AT $53,000,000. ALL OTHER CONTRACT TERMS AND CONDITIONS REMAIN UNCHANGED. |
| May 20, 2020 | P00001 | $53.0M | THE PURPOSE OF THIS MOD IS TO EXERCISE OPTION 1 CLIN 0003 - DOMESTIC MANUFACTURING SCALE-OUT DOMESTIC MANUFACTURING AT THE LONZA FACILITY IN NEW HAMPSHIRE |
| Apr 3, 2020 | 0 | $430.3M | DEVELOPMENT OF MRNA VACCINE TO LICENSURE FOR THE PREVENTION OF COVID-19. CLIN 0001 - PRE-AWARD COST, CLIN 0002 - DEVELOPMENT OF MRNA VACCINE TO BLA AND CLIN 0003 - DOMESTIC MANUFACTURING SCALE-OUT |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.